About 1 result found for searched term "Ogalvibart" (0.128 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M25197 | Ogalvibart | Anti-infection |
| C-135-LS; BMS-986414 | ||
| Ogalvibart (C-135-LS) is a humanized anti-SARS-CoV-2 monoclonal antibody (IgG1 type). Ogalvibart binds to the spike (S) glycoprotein receptor-binding domain (RBD) of SARS-CoV-2. Ogalvibart in combination with C144LS (1:1 ratio) shows good preventive activity and can effectively block the development of COVID19 in a rhesus monkey disease model. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
